Aptevo Therapeutics Inc (APVO)

$0.73 0.04 (5.53%)

15:59 EDT APVO Stock Quote Delayed 30 Minutes

Why Is Aptevo Therapeutics (APVO) Stock Down 56% Today?

By William White, InvestorPlace Writer Apr 11, 2024

Aptevo Therapeutics stock is falling on Thursday after the company priced a public offering for 3.4 million shares of APVO.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q4 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

More Articles

Volume:

Previous Close -

Market Cap 8.38M

PE Ratio -0.54

EPS -1.34

Volume (Avg. Vol.) 238,130

Day's Range $0.71 - $0.77

52-Week Range $0.13 - $10.80

Dividend & Yield N/A (N/A)

APVO Stock Predictions, Articles, and Aptevo Therapeutics Inc News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Aug 15, 2023

Pre-market stock movers are a hot topic with investors this morning and we're checking out the biggest ones worth watching on Tuesday!

Why Is Aptevo Therapeutics (APVO) Stock Down 33% Today?

By William White, InvestorPlace Writer Aug 2, 2023

Aptevo Therapeutics (APVO) stock is sliding lower on Wednesday after the biotechnology company announced a public share offering.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Aug 2, 2023

It's time for another breakdown of the biggest pre-market stock movers as we check out all of the latest news for Wednesday!

7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes

By Josh Enomoto, InvestorPlace Contributor Jul 30, 2023

Although speculative trades are not for everyone, these millionaire maker penny stocks could turn small bets into big returns.

The Top 7 Growth Stocks in Biotech

By Alex Sirois, InvestorPlace Contributor Mar 3, 2023

The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Jan 31, 2023

Investors can get ready for another busy day of trading with a breakdown of the biggest pre-market stock movers for Tuesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Dec 12, 2022

We're starting off the week with a look at the biggest pre-market stock movers traders need to know about for Monday morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Dec 13, 2021

Welcome back, investor! With our return from the weekend comes a dive into the biggest pre-market stock movers for Monday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Nov 24, 2021

We're starting the last day of this short holiday week with a dive into the biggest pre-market stock movers for Wednesday!

Aptevo Therapeutics News: Why APVO Stock Is Falling 15% Today

By William White, InvestorPlace Writer Nov 4, 2020

Aptevo Therapeutics (APVO) news for Wednesday includes APVO stock taking a fall after a strong rally yesterday on clinical trial results.

Aptevo Therapeutics down 25% after pricing $5M offering (NASDAQ:APVO)

From Seeking Alpha Aug 2, 2023

Aptevo Therapeutics (APVO) stock price dropped 25% as the company entered agreements with healthcare-focused institutional investors for the purchase and sale of ~8M shares at a...

Aptevo Skyrockets on Promising Clinical Data

From TipRanks Dec 12, 2022

Shares of biotechnology company Aptevo Therapeutics (NASDAQ:APVO) are skyrocketing today after the company announced promising data for its product candidate APVO43...

Recap: Aptevo Therapeutics Q1 Earnings

From Benzinga May 12, 2022

Aptevo Therapeutics (NASDAQ:APVO) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Aptevo Therapeutics Earnings Perspective: Return On Capital Employed

From Benzinga Mar 25, 2022

According to Benzinga Pro data, during Q4, Aptevo Therapeutics (NASDAQ:APVO) posted sales of $3.67 million. Earnings were up 10.36%, but Aptevo Therapeutics still reported an...

63 Biggest Movers From Yesterday

From Benzinga Mar 25, 2022

Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares gained 39.1% to close at $1.05 on Thursday. The company recently said its CFO Bruce Colwill will retire. Global Internet...

Aptevo Therapeutics: Q4 Earnings Insights

From Benzinga Mar 24, 2022

Aptevo Therapeutics (NASDAQ:APVO) reported its Q4 earnings results on Thursday, March 24, 2022 at 08:00 AM. Here's what investors need to know about the announcement....

ADVERTISEMENT